Articles

Google is looking to lock in an AI advantage with this move

With the launch of Gemini Enterprise, Google is betting that easy-to-build AI ‘agents’ are the key to unlocking the corporate market and boosting Alphabet shares.

Here’s what the OpenAI-AMD deal says about Nvidia

OpenAI says it’s buying AMD chips to get more compute power. Analysts also see benefits to diversifying away from Nvidia and likely securing favorable pricing.

Jamie Dimon says there’s a 30% chance of a correction. ‘I’m far more worried than others.’

The CEO of U.S. banking giant JPMorgan says most investors are not seeing the troubles that he is.

Delta’s stock rises as a recent acceleration in demand leads to record revenue

Delta’s stock surges, lifting those of its peers, after the air carrier beat earnings expectations as travel demand accelerated in recent weeks.

I’m having brain surgery. Will my heirs or the creditors get my money if I die?

“I’m 47 and have a small amount of investments totaling about $45,000, and I also have the same amount in debt.”

Ferrari’s stock suffers its worst day ever after capital-markets day

Ferrari, the premium sports-car maker with an equally expensive valuation, saw its worst day ever after a capital-market day presentation.

The bull market is turning 3 years old this week. Here’s where stocks are likely headed next.

What began as a tech-driven rally has started to broaden out. According to some on Wall Street, that should help power indexes like the S&P 500 even higher.

Social Security’s COLA increase could jump to 2.8% next year. That still isn’t enough for people to get by.

The cost-of-living adjustment can’t keep up with the actual cost of living, as retirees’ costs climb.

Novo Nordisk is paying up to $5.2 billion for a San Francisco biotech working on liver disease

Novo Nordisk, the Danish drugmaker behind Ozempic and other weight-loss drugs, said it’s paying up to $5.2 billion to buy Akero Therapeutics, a biotech with a drug in a late-stage trial to treat a fatal liver disease.

PepsiCo revenue grows even as beverage volumes keep falling — and its stock rises

PepsiCo saw an earnings beat and an improved full-year outlook, even as beverage volumes in North America extended their long streak of declines.

Strategist makes ‘jaw-dropping’ call — the dollar will rally, thanks to booming productivity

Steve Englander opines, “a productivity-driven increase in real interest rates is the most powerful driver a currency can have”

‘I watch antenna TV’: I’m 66. Will I lose my disability benefits if Social Security goes belly up?

“I read that the Social Security Disability Insurance Trust Fund is good until 2099.”
1 216 217 218 219 220 2,569